Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Performance of transrectal prostate biopsies in detecting tumours and implications for focal therapy.

Lahdensuo K, Mirtti T, Petas A, Rannikko A.

Scand J Urol. 2014 Jul 16:1-7. [Epub ahead of print]

PMID:
25028807
[PubMed - as supplied by publisher]
2.

Dabigatran for thromboprophylaxis after robotic assisted laparoscopic prostatectomy: retrospective analysis of safety profile and effect on blood coagulation.

Säily VM, Pétas A, Joutsi-Korhonen L, Taari K, Lassila R, Rannikko AS.

Scand J Urol. 2014 Apr;48(2):153-9. doi: 10.3109/21681805.2013.817482. Epub 2013 Jul 18.

PMID:
23865436
[PubMed - in process]
3.

[Update on current care guidelines: benign prostatic hyperplasia].

Tammela T, Nurmi M, Pétas A, Sipilä R, Taari K.

Duodecim. 2012;128(10):1046-7. Review. Finnish.

PMID:
22724320
[PubMed - indexed for MEDLINE]
4.

[Robotic laparoscopic radical prostatectomy].

Rannikko A, Pétas A, Tiippana E, Taari K.

Duodecim. 2011;127(6):623-31. Review. Finnish.

PMID:
21528527
[PubMed - indexed for MEDLINE]
5.

An 82-year-old Caucasian man with a ductal prostate adenocarcinoma with unusual cystoscopic appearance: a case report.

Sfoungaristos S, Katafigiotis IS, Tyritzis SI, Kavouras A, Kanatas P, Petas A.

J Med Case Rep. 2011 Jan 11;5:4. doi: 10.1186/1752-1947-5-4.

PMID:
21223563
[PubMed]
Free PMC Article
6.

Effect of dutasteride on the risk of prostate cancer.

Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS; REDUCE Study Group.

N Engl J Med. 2010 Apr 1;362(13):1192-202. doi: 10.1056/NEJMoa0908127.

PMID:
20357281
[PubMed - indexed for MEDLINE]
Free Article
7.

The effects of short-term oral phytoestrogen supplementation on the hypothalamic-pituitary-testicular axis in prostate cancer patients.

Rannikko A, Petas A, Raivio T, Jänne OA, Rannikko S, Adlercreutz H.

Prostate. 2006 Jul 1;66(10):1086-91.

PMID:
16637075
[PubMed - indexed for MEDLINE]
8.

Duration of testosterone suppression after a 9.45 mg implant of the GnRH-analogue buserelin in patients with localised carcinoma of the prostate a 12-month follow-up study.

Pettersson B, Varenhorst E, Petas A, Sandow J.

Eur Urol. 2006 Sep;50(3):483-9. Epub 2006 Mar 27.

PMID:
16626856
[PubMed - indexed for MEDLINE]
9.

Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestogen supplementation.

Rannikko A, Petas A, Rannikko S, Adlercreutz H.

Prostate. 2006 Jan 1;66(1):82-7.

PMID:
16114063
[PubMed - indexed for MEDLINE]
10.

Primary ureteroscopic treatment for obstructive ureteral stone-causing fornix rupture.

Kalafatis P, Zougkas K, Petas A.

Int J Urol. 2004 Dec;11(12):1058-64.

PMID:
15663675
[PubMed - indexed for MEDLINE]
11.

Tranexamic acid in control of primary hemorrhage during transurethral prostatectomy.

Rannikko A, Pétas A, Taari K.

Urology. 2004 Nov;64(5):955-8.

PMID:
15533485
[PubMed - indexed for MEDLINE]
12.

Viscoelastic memory and self-expansion of self-reinforced bioabsorbable stents.

Välimaa T, Laaksovirta S, Tammela TL, Laippala P, Talja M, Isotalo T, Pétas A, Tarri K, Törmälä P.

Biomaterials. 2002 Sep;23(17):3575-82.

PMID:
12109681
[PubMed - indexed for MEDLINE]
13.

Treatment of prostate cancer--any news?

Ruutu M, Mikkola A, Pétas A.

Ann Chir Gynaecol. 2001;90(1):5-9. Review. No abstract available.

PMID:
11336371
[PubMed - indexed for MEDLINE]
14.

A randomised study to evaluate the efficacy of a biodegradable stent in the prevention of postoperative urinary retention after interstitial laser coagulation of the prostate.

Pétas A, Isotalo T, Talja M, Tammela TL, Välimaa T, Törmälä P.

Scand J Urol Nephrol. 2000 Aug;34(4):262-6.

PMID:
11095085
[PubMed - indexed for MEDLINE]
15.

Bacterial adherence to self-reinforced polyglycolic acid and self-reinforced polylactic acid 96 urological spiral stents in vitro.

Pétas A, Vuopio-Varkila J, Siitonen A, Välimaa T, Talja M, Taari K.

Biomaterials. 1998 Apr-May;19(7-9):677-81.

PMID:
9663740
[PubMed - indexed for MEDLINE]
16.

Bioabsorbable and biodegradable stents in urology.

Talja M, Välimaa T, Tammela T, Petas A, Törmälä P.

J Endourol. 1997 Dec;11(6):391-7. Review.

PMID:
9440846
[PubMed - indexed for MEDLINE]
17.

Effects of biodegradable self-reinforced polyglycolic acid, poly-DL-lactic acid and stainless-steel spiral stents on uroepithelium after Nd:YAG laser irradiation of the canine prostate.

Pétas A, Kärkkäinen P, Talja M, Taari K, Laato M, Välimaa T, Törmälä P.

Br J Urol. 1997 Dec;80(6):903-7.

PMID:
9439406
[PubMed - indexed for MEDLINE]
18.
19.

A randomized study to compare biodegradable self-reinforced polyglycolic acid spiral stents to suprapubic and indwelling catheters after visual laser ablation of the prostate.

Pétas A, Talja M, Tammela T, Taari K, Lehtoranta K, Välimaa T, Törmälä P.

J Urol. 1997 Jan;157(1):173-6.

PMID:
8976244
[PubMed - indexed for MEDLINE]
20.

Bioabsorbable spiral stents in the urethra.

Tammela TL, Talja M, Petas A, Välimaa T, Törmälä P.

Scand J Urol Nephrol Suppl. 1996;179:97-100. No abstract available.

PMID:
8908673
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk